Symrise-Probi partnership to deliver probiotic goods in 2014-15

20-Dec-2012 - German fragrance and flavours house Symrise has just last night inked a deal with Swedish probiotics firm Probi to develop a stand-alone R&D project with oral probiotic supplements the most...

BASF wont extend Pronova offer again

20-Dec-2012 - BASF says it will not extend its offer for pharmaceutical-grade omega-3 supplier Pronova BioPharma ASA beyond new mid-January deadline.

update

Lonza teams with Sartorius on medias to boost capacity utilisation

20-Dec-2012 - A new culture media collaboration with Sartorius Stedim Biotech (SSB) will boost capacity utilisation and add revenue says Lonza. 

5-minute festive flick

Happy holidays from William Reed Business Media!

19-Dec-2012 - The working year is almost done, time to pause from ‘the business’ and embrace the festive season…go on, give it a big hug. Happy holidays!

Predicting most effective non-stick coatings will save Pharmas money, says I Holland

17-Dec-2012 - The ability to predict which non-stick coating is best suited to a particular tablet production environment will save drugmakers time and money according to I Holland.

Exclusive interview

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

13-Dec-2012 - BASF is moving en masse into omega-3 - especially if its bid for Norwegian player Pronova is approved - but it is technology gained from its May acquisition of a high-dose omega-3...

ICIG buys Tessenderlo's struggling pharma business

13-Dec-2012 - International Chemical Investors Group (ICIG) has bought Tessenderlo's underperforming European pharmaceutical intermediates and API business.

News in brief

IPEC Americas announces results of exec board elections

13-Dec-2012 - Representatives from Pfizer, J&J, Dow Corning and EMD Millipore will join IPEC Americas’ executive board and lead the excipient industry organisation as it moves to a new HQ.

Polypid tech shows promise for antibiotic delivery

13-Dec-2012 - Polypid says a new version of its lipid-polymer fusion-based technology has shown promise for the delivery of antibiotic in the treatment of bone fractures.

Merck Millipore says MAb process development kit cuts experimental burden

12-Dec-2012 - Merck Millipore hopes the promise of reducing the number of experiments needed during process development will win customers for its new MAb development kit.

BASF confident it can get omega-3 to pharma customers whatever the weather

12-Dec-2012 - Last week, BASF officially opened a pharmaceutical grade omega-3 active pharmaceutical ingredient (API) facility on the Isle of Lewis, Scotland that it gained with the acquisition of Equateq earlier this year ....

MHRA says 1,200 API plants may need inspecting under new import laws

11-Dec-2012 - The MHRA says as many as 1,200 active pharmaceutical ingredient (API) manufacturing plants may need to be inspected to secure UK supply chains when new EU import laws come into effect...

PSM says China counterfeit crackdown starting to work

11-Dec-2012 - A US advocacy group says Chinese crack down on counterfeiters is starting to work and that new Beijing unit will help.

BASF commits €22m as it expands Scottish omega-3 venture 1000%

10-Dec-2012 -

SDK invests in BIAsep to get resins know-how

10-Dec-2012 - Showa Denko KK (SDK) wants a share of the of the biopharmaceutical resins sector and has partnered with purification tech firm BIA Separations (BIASep) to get it.

update

Swissmedic welcomes EC ruling on APIs; CDSCO to oversee Indian exports to EU

06-Dec-2012 - Pharmaceutical industry regulator Swissmedic says inclusion on EU third-country list illustrates the high quality of APIs made in the country.

AMRI has biggest supply contract renewed by GE Healthcare

06-Dec-2012 - Contract manufacturing organisation (CMO) AMRI has had its largest commercial supply contract renewed by GE Healthcare.

CDER wants pill makers to find alternatives to DBP and DEHP plasticisers

06-Dec-2012 - The US CDER wants drugmakers to find alternatives to two common plasticisers used in tablet coating after studies link them to developmental and reproductive defects in animals.

GE says techs made at Cardiff lab will lower cell therapy development costs

05-Dec-2012 - GE Healthcare says new cell science lab in Wales will save drugmakers time and money and create more accurate alternatives to animal-based drug toxicity testing models.

Sartorius Stedim Biotech launches new 'nanofleece' prefilters for bioprocessing

05-Dec-2012 - Sartorius Stedim Biotech has launched a new ‘fleece-like’ prefiltration technology that it says better protects expensive downstream systems.

Sunwin Stevia pours cash into production

05-Dec-2012 - Sunwin Stevia International has invested heavily in production capacity to support declared growth plans in China.

News in brief

Safe Doses Act means longer sentences for drug thieves

05-Dec-2012 - Criminals who steal drugs to try and resell them into the legitimate supply chain face longer sentences under new US legislation.

EMA says mandatory supply chain risk assessments could prevent shortages

04-Dec-2012 - The EMA suggests that asking drugmakers to conduct risk assessments of manufacturing processes and supply chains could help prevent shortages. 

Guidance on PET sounds starting siren on 3-year NDA race

04-Dec-2012 - Positron emission tomography (PET) drug manufacturers have three years to gain NDA or ANDA approval or they must remove their products from the market according to the US FDA.

Access to Medicines says outsourced clinical trials need to be codified

03-Dec-2012 - The group whose comments on sponsor oversight drew criticism from ACRO says the industry group's preferred ‘trust and verify’ model only works if verification efforts are robust.

USP details new drug naming scheme

03-Dec-2012 - The USP says a new nomenclature scheme for salt drug substances will make for consistent product naming and ultimately help drugmakers.

Ranbaxy predicts shortages due to generic 'lipitor' manufacturing halt

03-Dec-2012 - Ranbaxy has predicted ‘market disruption’ after quality problems forced it to halt production of its generic version of Pfizer’s cholesterol buster Lipitor.